Sorrento Therapeutics and Mount Sinai join forces to develop Covid-19 antibody shield
Sorrento Therapeutics and Mount Sinai Health System in New York City have joined forces to develop an antibody cocktail they hope will shield against Covid-19 infection for up to two months.